Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Tax Provisions for 3 consecutive years, with $2000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Tax Provisions changed 0.0% to $2000.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $2000.0, a 200.0% increase, with the full-year FY2024 number at $2000.0, down 33.33% from a year prior.
  • Tax Provisions was $2000.0 for Q2 2025 at Inhibrx Biosciences, roughly flat from $2000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2000.0 in Q3 2023 to a low of -$4000.0 in Q4 2023.
  • A 3-year average of $500.0 and a median of $2000.0 in 2023 define the central range for Tax Provisions.
  • Biggest YoY gain for Tax Provisions was 0.0% in 2025; the steepest drop was 0.0% in 2025.
  • Inhibrx Biosciences' Tax Provisions stood at -$4000.0 in 2023, then soared by 150.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for INBX's Tax Provisions are $2000.0 (Q2 2025), $2000.0 (Q2 2024), and -$4000.0 (Q4 2023).